Antimicrobial resistance (AMR) remains one of the most formidable challenges to global health, with an estimated 4.7 million deaths annually attributed to infections resistant to standard treatments. While hospitals and clinical settings are often the focus of AMR discussions, a significant and often overlooked contributor to this crisis is the extensive use of antibiotics in animal agriculture. Approximately 70% of all antibiotics worldwide are administered to livestock, where insufficient oversight and fragmented regulatory frameworks have accelerated the emergence and dissemination of resistant bacteria. A recent groundbreaking comparative analysis published in Science in One Health sheds new light on the stark disparities in veterinary antimicrobial monitoring systems across three leading animal protein producers: the United Kingdom, the Netherlands, and Brazil.
Europe has emerged as a leader in addressing veterinary antimicrobial stewardship, exemplified by the sophisticated regulatory environments in the UK and the Netherlands. Both countries have implemented meticulous, mandatory surveillance mechanisms that capture every veterinary antimicrobial sale and use across the spectrum of livestock production. This high-resolution data collection is supported by active collaboration among veterinarians, farmers, regulatory agencies, and industry stakeholders, fostering a transparent and responsive governance model. This network enables policymakers to monitor antibiotic consumption trends in near real-time and design precision interventions aimed at curbing unnecessary or excessive use, thereby directly reducing the pressure driving resistance evolution.
In stark contrast, Brazil, a global powerhouse in meat production responsible for nearly 13% of the world’s animal protein supply, remains severely underprepared to tackle the AMR threat inherent in its agricultural practices. Despite Brazil’s economic weight and central role in the global food supply chain, the country currently lacks a cohesive national framework for veterinary antimicrobial monitoring. Sales data of veterinary antibiotics are not systematically collected or accessible to authorities, existing regulations are infrequently enforced, and there is a significant disconnect between official oversight and small-scale producers who operate largely outside regulatory reach. This fragmentation fundamentally cripples the capacity to assess antibiotic use accurately, identify misuse or overuse, and develop evidence-based policies to mitigate resistance risks.
The absence of robust antimicrobial surveillance in Brazil carries profound implications far beyond its borders. Resistant bacteria emerging in Brazilian livestock systems can easily spread internationally through exported meat products, threatening food safety and public health on a global scale. Furthermore, Brazil’s regulatory void poses a critical challenge to its agricultural export economy. As international markets increasingly demand transparent documentation verifying responsible antibiotic use, Brazil risks facing trade restrictions or loss of competitive advantage, jeopardizing one of its most valuable economic sectors. In this context, the effective monitoring and stewardship of veterinary antibiotics are not only public health imperatives but also strategic economic necessities.
A deeper technical examination reveals that the antimicrobial monitoring systems in the UK and the Netherlands integrate comprehensive digital databases that track antimicrobial sales at granular levels, enabling sector-specific interventions. These systems leverage advanced data analytics and reporting tools to identify hotspots of overuse or emerging resistance patterns in real-time, fostering an adaptive regulatory environment. Importantly, veterinarians in these countries are equipped with decision-support tools grounded in surveillance data, promoting responsible prescription practices aligned with One Health principles. This holistic approach demonstrates that synergistic stakeholder engagement coupled with rigorous data infrastructure is fundamental to containing AMR within livestock production.
Brazil’s challenges in establishing similar systems stem from multifaceted issues including infrastructural deficits, fragmented agricultural practices, and political complexities inhibiting regulatory enforcement. The current reliance on voluntary reporting and the absence of a centralized, interoperable database preclude effective nationwide surveillance. Moreover, socio-economic constraints among smallholders complicate the adoption of monitoring protocols, signaling the need for tailored capacity-building initiatives and incentivization mechanisms. Without addressing these systemic challenges, Brazil’s surveillance infrastructure will remain inadequate to meet both public health mandates and international trade expectations.
The study published in Science in One Health boldly calls for transformative reforms in Brazil aimed at closing these critical information gaps. It advocates for making antimicrobial sales and usage reporting mandatory across all layers of animal production, encompassing both large-scale exporters and small-scale farmers. Strengthening enforcement frameworks with credible penalties for non-compliance and aligning regulatory standards with international best practices are identified as essential steps to enhance transparency and accountability. The research also emphasizes the importance of cultivating robust partnerships between regulators, veterinary professionals, and producers to foster trust and facilitate the practical implementation of monitoring protocols.
Data empowerment emerges as a central theme in combating AMR effectively. Providing regulatory bodies with timely, reliable access to antimicrobial usage data allows for informed policymaking, early detection of resistance trends, and targeted interventions. The experience from European countries illustrates how integrating surveillance data into policy feedback loops can suffice not only in reducing antimicrobial consumption but also in preserving the efficacy of precious therapeutic agents critical to human and animal health. Without such data-driven governance, Brazil—and by extension the global community—remains vulnerable to unchecked resistance proliferation.
Ensuring global food safety necessitates concerted international cooperation, given that antimicrobial resistance does not recognize geopolitical boundaries. As the largest producer and exporter of multiple animal protein commodities, Brazil bears a heightened responsibility to harmonize its monitoring systems with global stewardship narratives. By embracing rigorous surveillance mechanisms and transparent reporting, Brazil can simultaneously safeguard public health, fulfill international trade obligations, and fortify its market competitiveness amidst increasing scrutiny on antimicrobial use in food production systems.
The findings of this new analysis highlight an urgent inflection point in the fight against AMR. While mature systems in Europe provide a proven blueprint for integrated antimicrobial stewardship, Brazil’s current state exposes dangerous vulnerabilities with global ramifications. However, the report offers a hopeful vision—one where strategic reforms and collaborative efforts can scaffold a comprehensive veterinary antimicrobial monitoring system that meets the highest standards of scientific rigor and regulatory efficacy. Such progress would mark a decisive leap forward in securing a safer, more sustainable food supply and preserving the therapeutic arsenal for future generations.
In conclusion, the battle against veterinary antimicrobial resistance demands immediate and sustained action grounded in robust surveillance and regulatory frameworks. The contrasting experiences of the UK, the Netherlands, and Brazil underscore the critical role of transparent data, stakeholder collaboration, and enforced policies in managing antibiotic use within animal agriculture. As antimicrobial resistance threatens to undermine decades of medical progress, global leadership—particularly from nations central to animal protein production—is indispensable. Brazil’s opportunity to transform its veterinary antimicrobial monitoring infrastructure represents not only an imperative public health investment but also a pivotal moment for global health security.
Subject of Research: Veterinary antimicrobial monitoring systems and antimicrobial resistance surveillance in animal agriculture
Article Title: Veterinary antimicrobial monitoring systems in Brazil, the United Kingdom, and the Netherlands: a descriptive comparison to support system development in Brazil
News Publication Date: 2-Apr-2026
Web References:
DOI:10.1016/j.soh.2026.100154
Image Credits: Jessica Kayamori Lopes, Briana Gomes, Bruno Machuca Thon, Saulo Henrique Weber, Ruan Rolnei Daros, Fernando Bittencourt Luciano, Claudia Turra Pimpao
Keywords: Antibiotics, Antimicrobial resistance, Veterinary medicine, Livestock, Surveillance systems, Regulatory frameworks, Brazil, United Kingdom, Netherlands, One Health, Food safety, Global health
